Understand the source comparison
AHK-Cu vs AHK Copper — Same Peptide, Different Names
The most common misconception about AHK-Cu versus AHK copper is that they represent different compounds requiring a side-by-side comparison. They don't. Both terms refer to the same tripeptide-copper complex. GHK-Cu (glycyl-L-histidyl-L-lysine bound to Cu²⁺).
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The most common misconception about AHK-Cu versus AHK copper is that they represent different compounds requiring a side-by-side comparison. They don't. Both terms refer to the same tripeptide-copper complex. GHK-Cu (glycyl-L-histidyl-L-lysine bound to Cu²⁺). And the naming variation exists purely because suppliers use different shorthand conventions. Our team at Real Peptides fields this question weekly from researchers who assume 'AHK' and 'GHK' represent structurally distinct molecules.
- Here's what creates the confusion: some suppliers label the compound using the full amino acid sequence (GHK), while others use the single-letter abbreviation (AHK). Alanine-Histidine-Lysine. The 'copper' or 'Cu' suffix simply indicates the metal ion chelated to the peptide backbone. The biological activity, molecular weight (approximately 340 Da), and mechanism of action remain identical regardless of label.
- What's the difference between AHK-Cu and AHK copper?
- There is no molecular difference. AHK-Cu and AHK copper are two names for the same copper peptide complex, GHK-Cu. The terms are used interchangeably across research literature and supplier catalogs. Both refer to a tripeptide (glycyl-L-histidyl-L-lysine) chelated to a copper ion (Cu²⁺), which acts as a signalling molecule in tissue remodelling, wound healing, and collagen synthesis studies. The only distinction is nomenclature preference. Some suppliers use 'AHK' as shorthand, others use 'GHK', and 'copper' versus 'Cu' are alternate ways to denote the metal component.
- The real question isn't which term is correct. It's which supplier's synthesis protocol, purity verification, and handling standards meet research-grade requirements. Every batch we produce undergoes HPLC and mass spectrometry validation to confirm the copper-peptide ratio sits within the narrow therapeutic window required for reproducible biological activity.